Back
ProShares UltraPro Short Dow30 Vs. Kymera Therapeutics Industry Stock Comparison
Sell
14
SDOW
ProShares UltraPro Short Dow30
Last Price:
12.44
Seasonality Move:
-18.32%
Buy
71
KYMR
Kymera Therapeutics
Last Price:
48.99
Seasonality Move:
65.72%
Sell
14
ProShares UltraPro Short Dow30 (SDOW)
is a Sell
Is ProShares UltraPro Short Dow30 a Buy, Sell or Hold?
- The current ProShares UltraPro Short Dow30 [SDOW] share price is $12.45. The Score for SDOW is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- SDOW is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SDOW Stock Price Chart
What is ProShares UltraPro Short Dow30's stock price today?
-
The ProShares UltraPro Short Dow30 share price today is $12.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SDOW is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SDOW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 33.82 | Sell |
| Chaikin Money Flow: | -10421018 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.81 - 13.81) | Sell |
| Bollinger Bands (100): | (13.76 - 16.76) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 59.12 | Buy |
| Chaikin Money Flow: | 317205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.81 - 49.49) | Buy |
| Bollinger Bands (100): | (34.86 - 47.92) | Buy |
SDOW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.85 | Sell |
| 20-day SMA: | 13.11 | Sell |
| 50-day SMA: | 14.15 | Sell |
| 200-day SMA: | 16.3 | Sell |
| 8-day EMA: | 12.77 | Sell |
| 20-day EMA: | 13.17 | Sell |
| 50-day EMA: | 13.97 | Sell |
| 200-day EMA: | 16.7 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.58 | Buy |
| 20-day SMA: | 46.67 | Buy |
| 50-day SMA: | 46.11 | Buy |
| 200-day SMA: | 38.62 | Buy |
| 8-day EMA: | 45.67 | Buy |
| 20-day EMA: | 45.85 | Buy |
| 50-day EMA: | 45.2 | Buy |
| 200-day EMA: | 38.5 | Buy |
ProShares UltraPro Short Dow30 Earnings Growth & SDOW Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
ProShares UltraPro Short Dow30 Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||